Tuberculosis continues to occur in New Zealand. Approximately 300 cases of TB are diagnosed each year.
Tuberculosis control in the 21st century faces many challenges at the global, regional and national level. The problems of poverty, adherence to treatment and stigma still prevail, while increasing drug resistance and HIV co-infection demand new approaches.
Due to a number of manufacturing issues which have affected global vaccine supplies, BCG vaccine was not available in New Zealand between 2016 and mid 2018. The vaccine is now available from public health community BCG vaccination clinics and in-hospital vaccinations. For more information see Resumption of BCG vaccination following vaccine shortage.
For more information on tuberculosis, including symptoms and immunisation information, go to the YourHealth consumer section.
Communicable Disease Control Manual 2012
The Communicable Disease Control Manual seeks to inform and assist those at the frontline of public health action, namely the medical officers of health, health protection officers and staff at public health units. The manual describes the standard practice that public health services would normally follow in regard to the prevention and control of notifiable diseases such as tuberculosis.
Guidelines for Tuberculosis Control in New Zealand 2010
Please note: This publication is currently under review.
Tuberculosis Case Management in Prisoners: Joint Protocol for Corrections Facilities and TB Treatment Supervising Services (Regional Public Health Services and/or Clinical TB Services) in New Zealand
This publication provides general information about TB, as well as more specific guidance on the practical aspects of TB case management of prisoners in corrections facilities.
Review of Neonatal BCG Immunisation Services in New Zealand
This review evaluates the neonatal BCG immunisation service in New Zealand.
Directly Observed Therapy (DOT) for Tuberculosis
Detection and cure remains the cornerstone of TB control. Directly observed therapy (DOT)ensures adherence. The Tuberculosis Working Group of the Ministry of Health strongly supports the use of DOT and urges all Medical Officers of Health to work with local medical practitioners to ensure that DOT is offered to all patients who are likely to benefit from it.